PharmiWeb.com - Global Pharma News & Resources
28-Jun-2019

Continuous Glucose Monitoring (CGM) Systems/Devices Market Size to Cross $ 2.2 Bn by 2026

The Global Continuous Glucose Monitoring (CGM) Systems/Devices Market Size is expected to reach USD 2.2 Billion by 2026 and growing CAGR around 14.3% during the forecast period 2018 - 2026.

The market is assessed to enlist a CAGR of 13.7% over the forecast period. Developing instances of diabetes and presentation of novel and propelled diabetes care gadgets are the central point driving the market development. Consistent glucose checking gadgets or glucose monitoring devices give an effective technique to gauge body glucose levels progressively in real time. Information recorded by these gadgets is transmitted through a remote system to recipients; this helps monitor glucose levels over an assigned period.

These gadgets likewise help manage diabetes while decreasing individual insulin measurements. Incorporated programming inside these gadgets furnishes clients with bits of knowledge about food consumption, physical activity, medication, and illnesses. Consequently, an expanding number of diabetic patients are utilizing these gadgets to oversee and treat diabetes, which, thusly, is quickening market development. With the coming of computerized therapeutics, a rising number of CGM gadgets are being joined with applications and programming to assist patients with diabetes mellitus. Ascend in the quantity of diabetes mellitus has been contributing toward market development.

Free Download Sample Report Pages For Better Understanding at https://www.acumenresearchandconsulting.com/request-sample/1160

The global Continuous Glucose Monitoring (CGM) Systems/Devices market is segmented into component, end-user, and region. On the basis of component, the global Continuous Glucose Monitoring (CGM) Systems/Devices market is segmented into transmitters amp; receivers, sensors, and insulin pumps. On the basis of end-user, the global Continuous Glucose Monitoring (CGM) Systems/Devices market is segmented into hospitals, homecare settings, and others. On the basis of region the global Continuous Glucose Monitoring (CGM) Systems/Devices market is bifurcated into Europe, Latin America, North America, Middle East amp; Africa, and Asia Pacific.

Developing instances of diabetes, combined with expanding adoption of continuous glucose monitoring (CGM) gadgets, has been driving the market. CGM frameworks are insignificantly obtrusive and offer a simple and compelling approach to manage diabetes. They can likewise recognize radical changes in blood glucose level, in this way avoiding hypoglycaemic conditions.

These gadgets encourage examination of blood glucose levels at various time interims with the assistance of a sensor. Individual readings nourished into to a diabetes the board programming through a remote system enable patients to comprehend the disease better, subsequently helping them to oversee it in a progressively powerful manner.

The North American district is relied upon to lead the worldwide market. Expanding instances of diabetes and endeavours taken by the national government to deal with the disease at a bigger dimension are required to drive the area's development. Rising adoption of exchange and novel gadgets have been seen in the area, accelerating market development. Preventive measures taken by the government to enable diabetic people to comprehend and deal with the illness before genuine results happen are the key driver for the regional market. The locale is relied upon to prosper attributable to technological advancements and considerable research and development in diabetes care.

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1160

Asia Pacific locale is foreseen to witness the most noteworthy CAGR during the forthcoming years. As per the Asian Diabetes Prevention Initiative, practically 60% of the world's diabetic populace resides in the Asia Pacific region. High commonness of the infection in emerging nations, for example, India and China has been pushing market development in the region. Additionally, rising healthcare expenditure, expanding investment and venture by organizations, and good regulatory approaches are likewise emphatically influencing the market development in this region.

The key players catering to the global Continuous Glucose Monitoring (CGM) Systems/Devices market are GlySens, Pfizer Inc., Ypsomed, Baxter International Inc., Novo Nordisk, Abbott Laboratories, Animas Corporation, and Medtronic, Inc. Significant strategic initiatives undertaken by global businesses include partnerships, new product launch, acquisitions. These players are engaged with different vital activities, for example, regional extension, collaboration efforts, benefit portfolio development, and mergers and acquisitions. Organizations are additionally progressively growing new products, which has additionally supported in the development of their current portfolio with progressive technologies. For example, in February, 2016 Animas Corporation declared the dispatch of Animas Academy in the Ireland and U.K., which is an instructive program for people managing diabetes with an insulin pump and strengthening innovation related with it.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Continuous Glucose Monitoring (CGM) Systems/Devices
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Continuous Glucose Monitoring (CGM) Systems/Devices Market By Component
1.2.2.1. Global Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue and Growth Rate Comparison By Component (2015-2026)
1.2.2.2. Global Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue Share By Component in 2017
1.2.2.3. Transmitters amp; Receivers
1.2.2.4. Sensors
1.2.2.5. Insulin Pumps
1.2.2.6. Others
1.2.3. Continuous Glucose Monitoring (CGM) Systems/Devices Market By End-use
1.2.3.1. Global Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue and Growth Rate Comparison By End-use (2015-2026)
1.2.3.2. Global Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue Share By End-use in 2017
1.2.3.3. Hospitals
1.2.3.4. Homecare Settings
1.2.3.5. Others
1.2.4. Continuous Glucose Monitoring (CGM) Systems/Devices Market by Geography
1.2.4.1. Global Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Continuous Glucose Monitoring (CGM) Systems/Devices Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Continuous Glucose Monitoring (CGM) Systems/Devices Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Continuous Glucose Monitoring (CGM) Systems/Devices Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Continuous Glucose Monitoring (CGM) Systems/Devices Major Manufacturers in 2017

CHAPTER 4. CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS/DEVICES MARKET BY COMPONENT

4.1. Global Continuous Glucose Monitoring (CGM) Systems/Devices Revenue By Component
4.2. Transmitters amp; Receivers
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Sensors
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Insulin Pumps
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Others
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS/DEVICES MARKET BY END-USE

5.1. Global Continuous Glucose Monitoring (CGM) Systems/Devices Revenue By End-use
5.2. Hospitals
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Homecare Settings
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS/DEVICES MARKET BY COUNTRY

6.1. North America Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue Share Comparison, 2015 amp; 2026 (%)
6.3. U.S.
6.3.1. U.S. Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS/DEVICES MARKET BY COUNTRY

7.1. Europe Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS/DEVICES MARKET BY COUNTRY

8.1. Asia-Pacific Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS/DEVICES MARKET BY COUNTRY

9.1. Latin America Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS/DEVICES MARKET BY COUNTRY

10.1. Middle East Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS/DEVICES MARKET BY COUNTRY

11.1. Africa Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Continuous Glucose Monitoring (CGM) Systems/Devices Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Component, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. GlySens
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Pfizer Inc.
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Ypsomed
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Baxter International Inc.
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Novo Nordisk
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Abbott Laboratories
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Animas Corporation
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Medtronic, Inc.
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Others
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/1160

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 28-Jun-2019